nodes	percent_of_prediction	percent_of_DWPC	metapath
Linagliptin—ABCB1—esophageal cancer	0.94	1	CbGaD
Linagliptin—Bronchial hyperreactivity—Methotrexate—esophageal cancer	0.00254	0.072	CcSEcCtD
Linagliptin—Diabetic—Methotrexate—esophageal cancer	0.00199	0.0563	CcSEcCtD
Linagliptin—DPP4—exocrine gland—esophageal cancer	0.00192	0.319	CbGeAlD
Linagliptin—Hypertriglyceridaemia—Capecitabine—esophageal cancer	0.00155	0.044	CcSEcCtD
Linagliptin—Infection—Carboplatin—esophageal cancer	0.00146	0.0414	CcSEcCtD
Linagliptin—Blood triglycerides increased—Capecitabine—esophageal cancer	0.00136	0.0385	CcSEcCtD
Linagliptin—DPP4—Peptide hormone metabolism—SLC30A7—esophageal cancer	0.00116	0.0632	CbGpPWpGaD
Linagliptin—Skin exfoliation—Cisplatin—esophageal cancer	0.00115	0.0327	CcSEcCtD
Linagliptin—ABCB1—Codeine and Morphine Metabolism—ABCC2—esophageal cancer	0.000967	0.0528	CbGpPWpGaD
Linagliptin—Skin exfoliation—Capecitabine—esophageal cancer	0.000851	0.0241	CcSEcCtD
Linagliptin—DPP4—epithelium—esophageal cancer	0.000834	0.139	CbGeAlD
Linagliptin—DPP4—smooth muscle tissue—esophageal cancer	0.000804	0.134	CbGeAlD
Linagliptin—Nasopharyngitis—Cisplatin—esophageal cancer	0.000785	0.0222	CcSEcCtD
Linagliptin—Diabetes mellitus—Capecitabine—esophageal cancer	0.000744	0.0211	CcSEcCtD
Linagliptin—Pancreatitis—Cisplatin—esophageal cancer	0.000744	0.0211	CcSEcCtD
Linagliptin—Pain in extremity—Capecitabine—esophageal cancer	0.000647	0.0183	CcSEcCtD
Linagliptin—DPP4—digestive system—esophageal cancer	0.000635	0.106	CbGeAlD
Linagliptin—Skin exfoliation—Methotrexate—esophageal cancer	0.000634	0.0179	CcSEcCtD
Linagliptin—DPP4—Peptide hormone metabolism—GHRL—esophageal cancer	0.000618	0.0338	CbGpPWpGaD
Linagliptin—CYP3A4—Codeine and Morphine Metabolism—ABCC2—esophageal cancer	0.000596	0.0325	CbGpPWpGaD
Linagliptin—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—esophageal cancer	0.000594	0.0324	CbGpPWpGaD
Linagliptin—Nasopharyngitis—Capecitabine—esophageal cancer	0.000579	0.0164	CcSEcCtD
Linagliptin—Diabetes mellitus—Methotrexate—esophageal cancer	0.000554	0.0157	CcSEcCtD
Linagliptin—Immune system disorder—Cisplatin—esophageal cancer	0.000549	0.0155	CcSEcCtD
Linagliptin—Mediastinal disorder—Cisplatin—esophageal cancer	0.000547	0.0155	CcSEcCtD
Linagliptin—DPP4—lung—esophageal cancer	0.00053	0.0882	CbGeAlD
Linagliptin—ABCB1—Drug Induction of Bile Acid Pathway—ABCC2—esophageal cancer	0.000529	0.0289	CbGpPWpGaD
Linagliptin—Malnutrition—Cisplatin—esophageal cancer	0.000529	0.015	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.00052	0.0147	CcSEcCtD
Linagliptin—Weight increased—Capecitabine—esophageal cancer	0.000509	0.0144	CcSEcCtD
Linagliptin—Infestation NOS—Capecitabine—esophageal cancer	0.000499	0.0141	CcSEcCtD
Linagliptin—Infestation—Capecitabine—esophageal cancer	0.000499	0.0141	CcSEcCtD
Linagliptin—Urinary tract infection—Capecitabine—esophageal cancer	0.000485	0.0137	CcSEcCtD
Linagliptin—CYP3A4—Fatty Acid Omega Oxidation—ADH7—esophageal cancer	0.000471	0.0257	CbGpPWpGaD
Linagliptin—Myalgia—Cisplatin—esophageal cancer	0.00045	0.0128	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000447	0.0127	CcSEcCtD
Linagliptin—Anaphylactic shock—Cisplatin—esophageal cancer	0.000431	0.0122	CcSEcCtD
Linagliptin—Infection—Cisplatin—esophageal cancer	0.000429	0.0121	CcSEcCtD
Linagliptin—Skin disorder—Cisplatin—esophageal cancer	0.000419	0.0119	CcSEcCtD
Linagliptin—CYP3A4—Tryptophan metabolism—ALDH3A2—esophageal cancer	0.000414	0.0226	CbGpPWpGaD
Linagliptin—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—esophageal cancer	0.000413	0.0226	CbGpPWpGaD
Linagliptin—Pancreatitis—Methotrexate—esophageal cancer	0.000408	0.0116	CcSEcCtD
Linagliptin—Immune system disorder—Capecitabine—esophageal cancer	0.000404	0.0115	CcSEcCtD
Linagliptin—Mediastinal disorder—Capecitabine—esophageal cancer	0.000403	0.0114	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000393	0.0111	CcSEcCtD
Linagliptin—Malnutrition—Capecitabine—esophageal cancer	0.00039	0.011	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000387	0.011	CcSEcCtD
Linagliptin—CYP3A4—Irinotecan Pathway—ABCC2—esophageal cancer	0.000381	0.0208	CbGpPWpGaD
Linagliptin—Back pain—Capecitabine—esophageal cancer	0.000377	0.0107	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000372	0.0106	CcSEcCtD
Linagliptin—Infestation—Methotrexate—esophageal cancer	0.000371	0.0105	CcSEcCtD
Linagliptin—Infestation NOS—Methotrexate—esophageal cancer	0.000371	0.0105	CcSEcCtD
Linagliptin—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—esophageal cancer	0.000366	0.02	CbGpPWpGaD
Linagliptin—DPP4—lymph node—esophageal cancer	0.000362	0.0604	CbGeAlD
Linagliptin—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—esophageal cancer	0.000349	0.0191	CbGpPWpGaD
Linagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—esophageal cancer	0.000341	0.0186	CbGpPWpGaD
Linagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—esophageal cancer	0.000341	0.0186	CbGpPWpGaD
Linagliptin—Cough—Capecitabine—esophageal cancer	0.00034	0.00963	CcSEcCtD
Linagliptin—Myalgia—Capecitabine—esophageal cancer	0.000332	0.0094	CcSEcCtD
Linagliptin—Arthralgia—Capecitabine—esophageal cancer	0.000332	0.0094	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000329	0.00933	CcSEcCtD
Linagliptin—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—esophageal cancer	0.000326	0.0178	CbGpPWpGaD
Linagliptin—ABCB1—Constitutive Androstane Receptor Pathway—ABCC2—esophageal cancer	0.000319	0.0174	CbGpPWpGaD
Linagliptin—Hypersensitivity—Cisplatin—esophageal cancer	0.000318	0.00901	CcSEcCtD
Linagliptin—CYP3A4—Codeine and Morphine Metabolism—ABCB1—esophageal cancer	0.000316	0.0173	CbGpPWpGaD
Linagliptin—Infection—Capecitabine—esophageal cancer	0.000316	0.00895	CcSEcCtD
Linagliptin—Skin disorder—Capecitabine—esophageal cancer	0.000309	0.00875	CcSEcCtD
Linagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—esophageal cancer	0.000304	0.0166	CbGpPWpGaD
Linagliptin—Immune system disorder—Methotrexate—esophageal cancer	0.000301	0.00853	CcSEcCtD
Linagliptin—Mediastinal disorder—Methotrexate—esophageal cancer	0.0003	0.00851	CcSEcCtD
Linagliptin—Diarrhoea—Cisplatin—esophageal cancer	0.000295	0.00836	CcSEcCtD
Linagliptin—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—esophageal cancer	0.000291	0.0159	CbGpPWpGaD
Linagliptin—ABCB1—ABC-family proteins mediated transport—ABCC2—esophageal cancer	0.00029	0.0159	CbGpPWpGaD
Linagliptin—Malnutrition—Methotrexate—esophageal cancer	0.00029	0.00822	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00029	0.00821	CcSEcCtD
Linagliptin—Back pain—Methotrexate—esophageal cancer	0.000281	0.00795	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000275	0.00778	CcSEcCtD
Linagliptin—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—esophageal cancer	0.000274	0.0149	CbGpPWpGaD
Linagliptin—Rash—Cisplatin—esophageal cancer	0.000272	0.00771	CcSEcCtD
Linagliptin—Constipation—Capecitabine—esophageal cancer	0.000272	0.0077	CcSEcCtD
Linagliptin—Dermatitis—Cisplatin—esophageal cancer	0.000272	0.0077	CcSEcCtD
Linagliptin—ABCB1—Constitutive Androstane Receptor Pathway—CYP2A6—esophageal cancer	0.000255	0.0139	CbGpPWpGaD
Linagliptin—Cough—Methotrexate—esophageal cancer	0.000253	0.00717	CcSEcCtD
Linagliptin—Urticaria—Capecitabine—esophageal cancer	0.000253	0.00716	CcSEcCtD
Linagliptin—Myalgia—Methotrexate—esophageal cancer	0.000247	0.007	CcSEcCtD
Linagliptin—Arthralgia—Methotrexate—esophageal cancer	0.000247	0.007	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000245	0.00695	CcSEcCtD
Linagliptin—Anaphylactic shock—Methotrexate—esophageal cancer	0.000237	0.00671	CcSEcCtD
Linagliptin—Infection—Methotrexate—esophageal cancer	0.000235	0.00666	CcSEcCtD
Linagliptin—Hypersensitivity—Capecitabine—esophageal cancer	0.000234	0.00664	CcSEcCtD
Linagliptin—Skin disorder—Methotrexate—esophageal cancer	0.00023	0.00652	CcSEcCtD
Linagliptin—CYP3A4—Xenobiotics—CYP2A6—esophageal cancer	0.000229	0.0125	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—XBP1—esophageal cancer	0.000228	0.0124	CbGpPWpGaD
Linagliptin—CYP3A4—Tamoxifen metabolism—CYP2A6—esophageal cancer	0.00022	0.012	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—SLC30A7—esophageal cancer	0.000218	0.0119	CbGpPWpGaD
Linagliptin—Diarrhoea—Capecitabine—esophageal cancer	0.000218	0.00616	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000216	0.00611	CcSEcCtD
Linagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—esophageal cancer	0.00021	0.0115	CbGpPWpGaD
Linagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—esophageal cancer	0.00021	0.0115	CbGpPWpGaD
Linagliptin—CYP3A4—digestive system—esophageal cancer	0.000207	0.0345	CbGeAlD
Linagliptin—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000204	0.00579	CcSEcCtD
Linagliptin—CYP3A4—Estrogen metabolism—CYP1B1—esophageal cancer	0.000201	0.011	CbGpPWpGaD
Linagliptin—Rash—Capecitabine—esophageal cancer	0.000201	0.00568	CcSEcCtD
Linagliptin—Dermatitis—Capecitabine—esophageal cancer	0.0002	0.00568	CcSEcCtD
Linagliptin—Headache—Capecitabine—esophageal cancer	0.000199	0.00564	CcSEcCtD
Linagliptin—DPP4—Metabolism of proteins—ST6GAL1—esophageal cancer	0.000197	0.0107	CbGpPWpGaD
Linagliptin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—esophageal cancer	0.000197	0.0107	CbGpPWpGaD
Linagliptin—ABCB1—epithelium—esophageal cancer	0.000193	0.0321	CbGeAlD
Linagliptin—Urticaria—Methotrexate—esophageal cancer	0.000188	0.00533	CcSEcCtD
Linagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—esophageal cancer	0.000187	0.0102	CbGpPWpGaD
Linagliptin—CYP3A4—Tamoxifen metabolism—CYP1B1—esophageal cancer	0.000177	0.00969	CbGpPWpGaD
Linagliptin—Hypersensitivity—Methotrexate—esophageal cancer	0.000174	0.00494	CcSEcCtD
Linagliptin—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—esophageal cancer	0.000173	0.00945	CbGpPWpGaD
Linagliptin—ABCB1—trachea—esophageal cancer	0.00017	0.0284	CbGeAlD
Linagliptin—Diarrhoea—Methotrexate—esophageal cancer	0.000162	0.00459	CcSEcCtD
Linagliptin—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—esophageal cancer	0.000157	0.00858	CbGpPWpGaD
Linagliptin—Rash—Methotrexate—esophageal cancer	0.000149	0.00423	CcSEcCtD
Linagliptin—Dermatitis—Methotrexate—esophageal cancer	0.000149	0.00423	CcSEcCtD
Linagliptin—Headache—Methotrexate—esophageal cancer	0.000148	0.0042	CcSEcCtD
Linagliptin—ABCB1—digestive system—esophageal cancer	0.000146	0.0244	CbGeAlD
Linagliptin—DPP4—Metabolism of proteins—ACTB—esophageal cancer	0.000136	0.0074	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—ENO1—esophageal cancer	0.000135	0.0074	CbGpPWpGaD
Linagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—esophageal cancer	0.000133	0.00729	CbGpPWpGaD
Linagliptin—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	0.000133	0.00724	CbGpPWpGaD
Linagliptin—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—esophageal cancer	0.000132	0.00719	CbGpPWpGaD
Linagliptin—CYP3A4—Tryptophan metabolism—ALDH2—esophageal cancer	0.000125	0.00683	CbGpPWpGaD
Linagliptin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABL1—esophageal cancer	0.000124	0.00679	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—HSPA5—esophageal cancer	0.000122	0.00669	CbGpPWpGaD
Linagliptin—ABCB1—lung—esophageal cancer	0.000122	0.0204	CbGeAlD
Linagliptin—DPP4—Metabolism of proteins—CALR—esophageal cancer	0.000119	0.00648	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—GHRL—esophageal cancer	0.000117	0.00637	CbGpPWpGaD
Linagliptin—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.000116	0.00635	CbGpPWpGaD
Linagliptin—DPP4—Metabolism of proteins—FBXW7—esophageal cancer	0.000115	0.00627	CbGpPWpGaD
Linagliptin—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.000108	0.00591	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—FKBP1A—esophageal cancer	0.000108	0.00588	CbGpPWpGaD
Linagliptin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—esophageal cancer	0.000104	0.0057	CbGpPWpGaD
Linagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	9.94e-05	0.00543	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—HMOX1—esophageal cancer	9.88e-05	0.0054	CbGpPWpGaD
Linagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	9.5e-05	0.00519	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—SMAD4—esophageal cancer	9.49e-05	0.00518	CbGpPWpGaD
Linagliptin—CYP3A4—Tryptophan metabolism—CYP1B1—esophageal cancer	9.47e-05	0.00518	CbGpPWpGaD
Linagliptin—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	9.38e-05	0.00512	CbGpPWpGaD
Linagliptin—CYP3A4—Tryptophan metabolism—CYP19A1—esophageal cancer	8.91e-05	0.00487	CbGpPWpGaD
Linagliptin—ABCB1—lymph node—esophageal cancer	8.37e-05	0.0139	CbGeAlD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—BBC3—esophageal cancer	8.35e-05	0.00456	CbGpPWpGaD
Linagliptin—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	8.19e-05	0.00448	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—HIF1A—esophageal cancer	7.76e-05	0.00424	CbGpPWpGaD
Linagliptin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	7.7e-05	0.00421	CbGpPWpGaD
Linagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	7.66e-05	0.00418	CbGpPWpGaD
Linagliptin—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	7.56e-05	0.00413	CbGpPWpGaD
Linagliptin—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	7.3e-05	0.00399	CbGpPWpGaD
Linagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	7.2e-05	0.00393	CbGpPWpGaD
Linagliptin—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	7.11e-05	0.00388	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—NOS2—esophageal cancer	7.06e-05	0.00386	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—ADH7—esophageal cancer	7.04e-05	0.00385	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—CREBBP—esophageal cancer	6.34e-05	0.00346	CbGpPWpGaD
Linagliptin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	6.21e-05	0.00339	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	6.18e-05	0.00337	CbGpPWpGaD
Linagliptin—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	5.84e-05	0.00319	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	5.74e-05	0.00314	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—esophageal cancer	5.68e-05	0.0031	CbGpPWpGaD
Linagliptin—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	5.66e-05	0.00309	CbGpPWpGaD
Linagliptin—ABCB1—Allograft Rejection—CASP8—esophageal cancer	5.52e-05	0.00301	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	5.34e-05	0.00292	CbGpPWpGaD
Linagliptin—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	5.27e-05	0.00288	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—esophageal cancer	5.19e-05	0.00284	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—esophageal cancer	4.94e-05	0.0027	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	4.91e-05	0.00268	CbGpPWpGaD
Linagliptin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—esophageal cancer	4.77e-05	0.00261	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	4.62e-05	0.00252	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	4.38e-05	0.00239	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	4.35e-05	0.00238	CbGpPWpGaD
Linagliptin—ABCB1—HIF-1-alpha transcription factor network—EP300—esophageal cancer	4.32e-05	0.00236	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	4.19e-05	0.00229	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—AQP3—esophageal cancer	4.17e-05	0.00228	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	4.14e-05	0.00226	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	4.09e-05	0.00224	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	4.05e-05	0.00221	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	4e-05	0.00219	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	4e-05	0.00219	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	3.88e-05	0.00212	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	3.84e-05	0.0021	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	3.3e-05	0.0018	CbGpPWpGaD
Linagliptin—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	3.25e-05	0.00178	CbGpPWpGaD
Linagliptin—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	3.1e-05	0.00169	CbGpPWpGaD
Linagliptin—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	3.06e-05	0.00167	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	3.03e-05	0.00166	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—GNG7—esophageal cancer	2.75e-05	0.0015	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	2.72e-05	0.00149	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	2.71e-05	0.00148	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—BLVRB—esophageal cancer	2.7e-05	0.00148	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—SLC52A3—esophageal cancer	2.7e-05	0.00148	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	2.34e-05	0.00128	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CA1—esophageal cancer	2.3e-05	0.00126	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—SLC10A2—esophageal cancer	2.3e-05	0.00126	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	2.27e-05	0.00124	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	2.22e-05	0.00121	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CA2—esophageal cancer	2.1e-05	0.00115	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	2e-05	0.0011	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PLCE1—esophageal cancer	1.96e-05	0.00107	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ADH7—esophageal cancer	1.96e-05	0.00107	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	1.94e-05	0.00106	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	1.85e-05	0.00101	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ADH1B—esophageal cancer	1.71e-05	0.000937	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	1.68e-05	0.000916	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—BLVRB—esophageal cancer	1.67e-05	0.00091	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—SLC52A3—esophageal cancer	1.67e-05	0.00091	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—TYMP—esophageal cancer	1.64e-05	0.000895	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	1.61e-05	0.000878	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CYP26A1—esophageal cancer	1.59e-05	0.000871	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	1.57e-05	0.000859	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ALOX15—esophageal cancer	1.55e-05	0.000849	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GSTO1—esophageal cancer	1.48e-05	0.00081	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—TPI1—esophageal cancer	1.48e-05	0.00081	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ALDOB—esophageal cancer	1.42e-05	0.000776	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CA1—esophageal cancer	1.42e-05	0.000774	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—SLC10A2—esophageal cancer	1.42e-05	0.000774	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GAPDH—esophageal cancer	1.37e-05	0.000747	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	1.37e-05	0.000746	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CRABP1—esophageal cancer	1.36e-05	0.00074	CbGpPWpGaD
Linagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	1.32e-05	0.000721	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CA2—esophageal cancer	1.3e-05	0.000708	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GNG7—esophageal cancer	1.29e-05	0.000704	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ALDH2—esophageal cancer	1.21e-05	0.00066	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PLCE1—esophageal cancer	1.2e-05	0.000658	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ADH7—esophageal cancer	1.2e-05	0.000658	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—GSTT1—esophageal cancer	1.15e-05	0.000628	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CYP2A6—esophageal cancer	1.14e-05	0.00062	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PTGS1—esophageal cancer	1.08e-05	0.000588	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—ENO1—esophageal cancer	1.08e-05	0.000588	CbGpPWpGaD
Linagliptin—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.08e-05	0.000588	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PSME2—esophageal cancer	1.06e-05	0.00058	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PSME1—esophageal cancer	1.06e-05	0.00058	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ADH1B—esophageal cancer	1.06e-05	0.000577	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—TYMP—esophageal cancer	1.01e-05	0.000552	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CYP26A1—esophageal cancer	9.82e-06	0.000537	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ALOX15—esophageal cancer	9.57e-06	0.000523	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CYP1B1—esophageal cancer	9.16e-06	0.0005	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—TPI1—esophageal cancer	9.13e-06	0.000499	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GSTO1—esophageal cancer	9.13e-06	0.000499	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ALDOB—esophageal cancer	8.75e-06	0.000478	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CYP19A1—esophageal cancer	8.61e-06	0.00047	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GAPDH—esophageal cancer	8.43e-06	0.00046	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CRABP1—esophageal cancer	8.35e-06	0.000456	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GNG7—esophageal cancer	7.94e-06	0.000434	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—HMOX1—esophageal cancer	7.85e-06	0.000429	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ALDH2—esophageal cancer	7.44e-06	0.000407	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—GSTT1—esophageal cancer	7.08e-06	0.000387	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CYP2A6—esophageal cancer	7e-06	0.000382	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ENO1—esophageal cancer	6.63e-06	0.000362	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PTGS1—esophageal cancer	6.63e-06	0.000362	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PSME1—esophageal cancer	6.54e-06	0.000357	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PSME2—esophageal cancer	6.54e-06	0.000357	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CYP1B1—esophageal cancer	5.64e-06	0.000308	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CYP19A1—esophageal cancer	5.3e-06	0.00029	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—CREBBP—esophageal cancer	5.04e-06	0.000275	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—HMOX1—esophageal cancer	4.84e-06	0.000264	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—ABCB1—esophageal cancer	4.65e-06	0.000254	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—NOS3—esophageal cancer	4.51e-06	0.000246	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PTGS2—esophageal cancer	4.13e-06	0.000225	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—EP300—esophageal cancer	3.43e-06	0.000187	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—CREBBP—esophageal cancer	3.1e-06	0.00017	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—NOS3—esophageal cancer	2.78e-06	0.000152	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PTGS2—esophageal cancer	2.54e-06	0.000139	CbGpPWpGaD
Linagliptin—ABCB1—Metabolism—PIK3CA—esophageal cancer	2.54e-06	0.000139	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—EP300—esophageal cancer	2.11e-06	0.000116	CbGpPWpGaD
Linagliptin—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.56e-06	8.54e-05	CbGpPWpGaD
